Award
National Heart, Lung, and Blood Institute 4R33HL167909-02
A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations
Recipient
UT SOUTHWESTERN MEDICAL CENTER
Award Amount
$806,508.00
Ceiling
$806,508.00
Awarded
September 19, 2025
Identifier
4R33HL167909-02
NIH grant awarded to UT Southwestern Medical Center for a clinical trial studying SSRIs in asthma patients, focusing on asthma control and quality of life outcomes.
Description
This is a NIH grant project for a clinical trial involving the use of SSRIs for asthma patients. The project includes a milestone-driven start-up phase and a subsequent randomized controlled trial. The project aims to assess primary outcomes such as steroid burst needs, asthma control, and quality of life, along with secondary measures including serum IL-6 levels and exhaled nitric oxide. The project involves collaboration with experienced investigators in asthma and clinical trials.